本文關(guān)鍵詞： Z醫(yī)藥 企業(yè)文化 建設(shè) 測(cè)量　出處：《廣東財(cái)經(jīng)大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：Z醫(yī)藥有限公司(簡(jiǎn)稱“Z醫(yī)藥”)于1951年組建,是我國(guó)規(guī)模最大的合資藥企,其由“廣藥集團(tuán)”與全球500強(qiáng)“聯(lián)合博姿”共同投資所創(chuàng)建,下屬成員企業(yè)包括健民、欣特、器化、國(guó)盈醫(yī)藥等子公司共22家。該公司在2015年共實(shí)現(xiàn)378.23億元的銷售收入,相較于上年度實(shí)現(xiàn)了12.8%的增幅,利潤(rùn)同比實(shí)現(xiàn)了7.17%的增幅。然而,盡管企業(yè)發(fā)展較為良好,但因競(jìng)爭(zhēng)的加劇、市場(chǎng)環(huán)境的較大變化及愈加增大的員工年齡斷層的影響,加之逐步增加的配送中心與異地成員企業(yè),使得Z醫(yī)藥的管理層愈加認(rèn)識(shí)到在公司管理中文化力所發(fā)揮的重大作用。經(jīng)歷65年的發(fā)展,Z醫(yī)藥已實(shí)現(xiàn)具有自身獨(dú)特性的企業(yè)文化的構(gòu)建,這樣的文化基礎(chǔ)能夠從何種層面推動(dòng)公司的發(fā)展?要使企業(yè)文化理念真正為員工所認(rèn)同,并實(shí)現(xiàn)其自覺踐行與遵守,需要對(duì)文化體系進(jìn)行怎樣的梳理?又應(yīng)該怎樣對(duì)新并購(gòu)企業(yè)實(shí)施文化整合?Z醫(yī)藥應(yīng)如何與自身發(fā)展特點(diǎn)相結(jié)合,進(jìn)行發(fā)展企業(yè)文化的規(guī)劃與戰(zhàn)略的制定,進(jìn)而推動(dòng)企業(yè)文化的傳承與發(fā)展?論文以上述問題為對(duì)象,并與Z醫(yī)藥的現(xiàn)實(shí)相結(jié)合,根據(jù)涵蓋公平獎(jiǎng)懲、社會(huì)責(zé)任、關(guān)心員工、人際和諧、規(guī)范整合、勇于創(chuàng)新、顧客導(dǎo)向等內(nèi)容的企業(yè)文化量表進(jìn)行診斷與評(píng)估,深入剖析與研究該司企業(yè)文化建設(shè)所存在的問題及積累的優(yōu)秀經(jīng)驗(yàn),以為企業(yè)文化建設(shè)的完善提供有效的借鑒。其次,以診斷結(jié)果為依據(jù),針對(duì)Z企業(yè)醫(yī)藥文化的提升制定了相應(yīng)的對(duì)策及可行性方案。最后,對(duì)論文進(jìn)行總結(jié),提出Z醫(yī)藥應(yīng)以“一個(gè)Z醫(yī)藥”為核心,進(jìn)行戰(zhàn)略目標(biāo)、企業(yè)文化、品牌形象、戰(zhàn)略布局、績(jī)效管理、企業(yè)能力等內(nèi)容的構(gòu)建與完善。本論文以Z醫(yī)藥企業(yè)文化建設(shè)為對(duì)象進(jìn)行了發(fā)展路徑的探尋,為同行業(yè)企業(yè)的發(fā)展提供了有效的借鑒。
[Abstract]:Z Pharmaceutical Co., Ltd. (referred to as "Z Medicine") was established in 1951, is the largest joint venture pharmaceutical enterprise in China, which was founded by the "Guang Pharmaceutical Group" and the Global Top 500 "combined Bozi" co-investment. The subsidiary companies include Jianmin, Hint, Qihua, Guoying Pharmaceutical Co., Ltd. In 2015, the company achieved a total sales income of thirty-seven billion eight hundred and twenty-three million yuan. Profits rose by 7.17% from a year earlier, compared with an increase of 12.8% in the previous year. However, despite better corporate growth, competition has intensified. Greater changes in the market environment and the growing age gap of employees, coupled with a gradual increase in distribution centers and foreign member enterprises. The management of Z medicine has become more aware of the important role of cultural power in the management of the company. After 65 years of development, Z medicine has realized the construction of its own unique corporate culture. At what level can such a cultural foundation contribute to the development of the company? In order to make the concept of corporate culture truly recognized by the employees and to realize its conscious practice and compliance, what kind of sort of cultural system should be combed? And how to implement the cultural integration of new M & A enterprises? How to combine Z medicine with its own development characteristics to develop corporate culture planning and strategy, and then promote the inheritance and development of corporate culture? The paper takes the above problems as the object and combines with the reality of Z medicine, according to the cover of fair reward and punishment, social responsibility, care for employees, interpersonal harmony, normative integration, dare to innovate. Customer orientation and other content of corporate culture scale for diagnosis and evaluation, in-depth analysis and study of the division's corporate culture construction problems and accumulated outstanding experience. For the improvement of corporate culture construction to provide an effective reference. Secondly, based on the diagnosis results, for the promotion of medical culture in Z enterprise to formulate the corresponding countermeasures and feasibility plans. Finally, the paper summarized. It is pointed out that Z medicine should take "one Z medicine" as the core, and carry out strategic objectives, corporate culture, brand image, strategic layout and performance management. This paper takes Z pharmaceutical enterprise culture construction as the object to explore the development path, which provides an effective reference for the development of the same industry enterprises.
【學(xué)位授予單位】：廣東財(cái)經(jīng)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：F426.72;F270

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 辛杰;;企業(yè)文化對(duì)企業(yè)社會(huì)責(zé)任的影響:領(lǐng)導(dǎo)風(fēng)格與高管團(tuán)隊(duì)行為整合的作用[J];上海財(cái)經(jīng)大學(xué)學(xué)報(bào);2014年06期

2 趙憶;楊育;;基于FCA的國(guó)有集團(tuán)下屬單位企業(yè)文化落地績(jī)效影響因素分析[J];機(jī)械;2012年07期

3 李海;張勉;;企業(yè)文化是核心競(jìng)爭(zhēng)力嗎?——文化契合度對(duì)企業(yè)績(jī)效的影響[J];中國(guó)軟科學(xué);2012年04期

4 張仁江;李海月;;企業(yè)文化與組織績(jī)效關(guān)系研究[J];現(xiàn)代管理科學(xué);2010年04期

5 朱兵;王文平;王為東;張廷龍;;企業(yè)文化、組織學(xué)習(xí)對(duì)創(chuàng)新績(jī)效的影響[J];軟科學(xué);2010年01期

6 胡瑋瑋;姚先國(guó);;組織文化、知識(shí)管理戰(zhàn)略與績(jī)效關(guān)系研究[J];科研管理;2009年06期

7 倪宏偉;王元龍;;企業(yè)文化管理邏輯的探討[J];企業(yè)管理;2009年05期

8 李庚;;日本企業(yè)文化對(duì)我國(guó)文化建設(shè)的啟示[J];經(jīng)濟(jì)與社會(huì)發(fā)展;2009年04期

9 葛紅巖;;基于企業(yè)文化視角的企業(yè)環(huán)境構(gòu)建[J];特區(qū)經(jīng)濟(jì);2008年08期

10 董小英;劉倩倩;尹德志;;Business Performance, Business Strategy, and Information System Strategic Alignment: An Empirical Study on Chinese Firms[J];Tsinghua Science and Technology;2008年03期

相關(guān)博士學(xué)位論文 前2條

1 陳洪瑋;企業(yè)文化管理對(duì)企業(yè)績(jī)效作用的理論與實(shí)證研究[D];南昌大學(xué);2008年

2 陳靜;企業(yè)文化提升企業(yè)核心競(jìng)爭(zhēng)力的機(jī)制與路徑研究[D];武漢理工大學(xué);2007年

相關(guān)碩士學(xué)位論文 前3條

1 朱宇霞;泰州煙草公司企業(yè)文化建設(shè)研究[D];安徽大學(xué);2012年

2 何宏兵;中國(guó)大陸企業(yè)文化建設(shè)研究[D];蘇州大學(xué);2012年

3 易志明;中國(guó)藥品流通企業(yè)發(fā)展模式研究[D];對(duì)外經(jīng)濟(jì)貿(mào)易大學(xué);2006年

，

本文編號(hào)：1479447